STOCK TITAN
  1. Home
  2. Sec-filings
  3. PRVA
  4. [8-K] Privia Health Group, Inc. Reports Material Event

Board member Shawn Morris exits Privia Health (NASDAQ: PRVA) role

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Privia Health Group, Inc. announced that Shawn Morris resigned from its Board of Directors and from the Board’s Compliance Committee, effective July 6, 2026. The company states that his departure is not due to any disagreement regarding operations, policies, or practices.

The Board and the company thank Mr. Morris for his dedicated service and contributions during his tenure. The filing is signed on behalf of Privia Health Group, Inc. by Chief Executive Officer Parth Mehrotra.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Board of Directors financial
"resigned from his position as a member of the Board of Directors"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
Compliance Committee financial
"and as a member of the Compliance Committee of the Board"
principal officers financial
"Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →

FAQ

What board change did Privia Health Group (PRVA) disclose?
Privia Health Group disclosed that Shawn Morris resigned from its Board of Directors and the Compliance Committee, effective July 6, 2026. The company emphasized appreciation for his service and acknowledged his insights and contributions during his tenure.

Did Shawn Morris leave Privia Health (PRVA) over a disagreement?
The company states that Shawn Morris’s resignation was not due to any disagreement with Privia Health on operations, policies, or practices. This language is meant to reassure investors that his departure is not tied to internal disputes.

What committee role did Shawn Morris hold at Privia Health (PRVA)?
In addition to serving on the Board of Directors, Shawn Morris was a member of Privia Health’s Compliance Committee. His resignation covers both roles and became effective immediately on July 6, 2026, according to the company’s disclosure.

Who signed the Privia Health (PRVA) report about the director resignation?
The report detailing Shawn Morris’s resignation was signed on behalf of Privia Health Group, Inc. by Chief Executive Officer Parth Mehrotra. This signature confirms the company’s official acknowledgment and approval of the disclosed board changes.

When did Privia Health (PRVA) make the director resignation effective?
Shawn Morris’s resignation from the Privia Health Board and its Compliance Committee was effective July 6, 2026. The company later executed the report on July 7, 2026, formally documenting the governance change for investors and regulators.
0001759655FALSE00017596552026-07-062026-07-06

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________
FORM 8-K
_______________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 6, 2026
_________________________
Privia Health Group, Inc.
(Exact Name of Registrant as Specified in Its Charter)
_________________________
Delaware
001-4036581-3599420
(State or other jurisdiction of incorporation or organization)
(Commission
File No.)
(I.R.S. Employer Identification No.)
950 N. Glebe Rd.,
Suite 700
Arlington,Virginia22203
(Address of Principal Executive Offices)
(Zip Code)
(571) 366-8850
Registrant's telephone number, including area code

Not Applicable
(Former name, former address and former fiscal year, if changed since last report)

Check the appropriate box below if the form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2 (b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.01 par value per sharePRVAThe Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
On July 6, 2026, Shawn Morris resigned from his position as a member of the Board of Directors (the “Board”) of Privia Health Group, Inc. (the “Company”) and as a member of the Compliance Committee of the Board, effective immediately. Mr. Morris’s resignation was not due to any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices. The Company and the Board express their sincere gratitude to Mr. Morris for his dedicated service, valuable insights, and contributions to the Company during his tenure.



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

PRIVIA HEALTH GROUP, INC.
Date: July 7, 2026
By:/s/ Parth Mehrotra
Name: Parth Mehrotra
Title: Chief Executive Officer

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

3 documents

Other Documents